1. Comparative transcriptomic analyses of thymocytes using 10x Genomics and Parse scRNA-seq technologies.
- Author
-
Filippov I, Philip CS, Schauser L, and Peterson P
- Subjects
- Animals, Mice, Sequence Analysis, RNA methods, Transcriptome, RNA-Seq methods, Single-Cell Gene Expression Analysis, Thymocytes metabolism, Thymocytes cytology, Single-Cell Analysis methods, Genomics methods, Gene Expression Profiling methods
- Abstract
Background: Single-cell RNA sequencing experiments commonly use 10x Genomics (10x) kits due to their high-throughput capacity and standardized protocols. Recently, Parse Biosciences (Parse) introduced an alternative technology that uses multiple in-situ barcoding rounds within standard 96-well plates. Parse enables the analysis of more cells from multiple samples in a single run without the need for additional reagents or specialized microfluidics equipment. To evaluate the performance of both platforms, we conducted a benchmark study using biological and technical replicates of mouse thymus as a complex immune tissue., Results: We found that Parse detected nearly twice the number of genes compared to 10x, with each platform detecting a distinct set of genes. The comparison of multiplexed samples generated from 10x and Parse techniques showed 10x data to have lower technical variability and more precise annotation of biological states in the thymus compared to Parse., Conclusion: Our results provide a comprehensive comparison of the suitability of both single-cell platforms for immunological studies., Competing Interests: Declarations Ethics approval and consent to participate This study was conducted in accordance to the permission from the Ministry of Regional Affairs and Agriculture (Estonia) and approved by the Animal Experiments Ethics Committee at the Ministry (Protocol No. 224). All methods were performed in accordance with relevant guidelines and regulations. This study was carried out in compliance with the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments). Consent for publication Not applicable. Competing interests The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF